Adaptimmune Therapeutics PLC (ADAP): The company said it will regain rights t...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Adaptimmune Therapeutics PLC (ADAP)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	2791
Boards Moderated	3
Alias Born	10/24/2015

Re: None

Tuesday, 04/11/2023 2:54:34 PM

Tuesday, April 11, 2023 2:54:34 PM

The company said it will regain rights to the PRAME and NY-ESO-1 programs from GSK. Adaptimmune will receive an upfront payment plus milestone-based payments totalling £30M related to the transfer of the clinical trials for the NY-ESO-1 programs.

The companies will transition materials and data related to the preclinical PRAME targeted TCR T-cell therapy program to Adaptimmune during 2023. The companies are targeting transfer of sponsorship for GSK's IGNYTE-ESO trial (NCT03967223) and long-term follow-up (NCT03391778) during Q3. The companies noted that all other trials within the NY-ESO-1 targeting program are already closed to enrollment and have already been or will soon be completed by GSK.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADAP News

Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 12:05:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:13:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:05:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:07:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:31:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:30:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:02:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:02:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:01:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:00:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:00:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:46:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 12:13:01 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/30/2023 09:16:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:05:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 12:37:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:15:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:07:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 09:19:52 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/10/2023 08:05:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:06:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 11:42:57 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 09:00:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:16 PM

More ADAP News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow